Edge Capital Group, LLC Astrazeneca PLC Transaction History

Edge Capital Group, LLC

$2.21 Billion
Q3 2024

A detailed history of Edge Capital Group, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Edge Capital Group, LLC holds 144,010 shares of AZN stock, worth $9.41 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

144,010

Previous 144,301 0.2%

Holding current value

$9.41 Million

Previous $11.3 Million 0.29%

% of portfolio

0.51%

Previous 0.55%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$76.67 - $87.62 $22,310 - $25,497	-291 Reduced 0.2%	144,010 $11.2 Million
Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $244,858 - $296,241	3,665 Added 2.61%	144,301 $11.3 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $83,550 - $95,241	1,369 Added 0.98%	140,636 $9.53 Million
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $61,766 - $69,141	-998 Reduced 0.71%	139,267 $9.38 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $286,961 - $317,272	-4,425 Reduced 3.06%	140,265 $9.5 Million
Q2 2023 Aug 08, 2023	SELL	$69.91 - $75.81 $399,815 - $433,557	-5,719 Reduced 3.8%	144,690 $10.4 Million
Q1 2023 May 04, 2023	SELL	$63.15 - $71.6 $742,138 - $841,443	-11,752 Reduced 7.25%	150,409 $10.4 Million
Q4 2022 Feb 07, 2023	SELL	$54.21 - $70.44 $158,347 - $205,755	-2,921 Reduced 1.77%	162,161 $11 Million
Q3 2022 Nov 09, 2022	BUY	$53.02 - $135.75 $75,977 - $194,529	1,433 Added 0.88%	165,082 $9.05 Million
Q2 2022 Aug 08, 2022	SELL	$59.26 - $71.14 $154,431 - $185,390	-2,606 Reduced 1.57%	163,649 $10.8 Million
Q1 2022 May 03, 2022	SELL	$55.72 - $67.12 $178,081 - $214,515	-3,196 Reduced 1.89%	166,255 $11 Million
Q4 2021 Jan 19, 2022	SELL	$54.02 - $63.83 $104,852 - $123,894	-1,941 Reduced 1.13%	169,451 $9.87 Million
Q3 2021 Oct 26, 2021	SELL	$55.56 - $60.79 $319,136 - $349,177	-5,744 Reduced 3.24%	171,392 $10.3 Million
Q2 2021 Aug 09, 2021	BUY	$48.42 - $60.18 $2.93 Million - $3.65 Million	60,576 Added 51.97%	177,136 $10.6 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $5.5 Million - $6.35 Million	116,560 New	116,560 $5.8 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Capital Group, LLC with notifications on news.

Account

Edge Capital Group, LLC Astrazeneca PLC Transaction History